These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 8661952

  • 21. [Effects of salmon calcitonin in treatment of osteoporosis in patients undergoing dialysis].
    Wang SX, Li H.
    Zhonghua Yi Xue Za Zhi; 2008 Feb 05; 88(6):387-90. PubMed ID: 18581891
    [Abstract] [Full Text] [Related]

  • 22. [Effect of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis].
    Liu JL, Zhu HM, Huang QR, Zhang ZL, Li HL, Qin YJ, Zhang Y, Wei DL, Lu JH, Liu H, Chen XP, Liu YJ, Ekangaki A, Zheng YM, Diez-Perez A, Harpe K.
    Zhonghua Yi Xue Za Zhi; 2004 Feb 17; 84(4):269-73. PubMed ID: 15059505
    [Abstract] [Full Text] [Related]

  • 23. Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.
    Lems WF, Lodder MC, Lips P, Bijlsma JW, Geusens P, Schrameijer N, van de Ven CM, Dijkmans BA.
    Osteoporos Int; 2006 Feb 17; 17(5):716-23. PubMed ID: 16463007
    [Abstract] [Full Text] [Related]

  • 24. Effect of ipriflavone on bone mineral density and calcium-related factors in elderly females.
    Nakamura S, Morimoto S, Takamoto S, Onishi T, Fukuo K, Koh E, Kitano S, Miyashita Y, Yasuda O, Tamatani M.
    Calcif Tissue Int; 1992 Feb 17; 51 Suppl 1():S30-4. PubMed ID: 1422983
    [Abstract] [Full Text] [Related]

  • 25. The effect of season and vitamin D supplementation on bone mineral density in healthy women: a double-masked crossover study.
    Patel R, Collins D, Bullock S, Swaminathan R, Blake GM, Fogelman I.
    Osteoporos Int; 2001 Feb 17; 12(4):319-25. PubMed ID: 11420782
    [Abstract] [Full Text] [Related]

  • 26. Comparison of calcium and alfacalcidol supplement in the prevention of osteopenia after kidney transplantation.
    Berczi C, Asztalos L, Kincses Z, Balogh A, Löcsey L, Balázs G, Lukács G.
    Osteoporos Int; 2003 Jun 17; 14(5):412-7. PubMed ID: 12730763
    [Abstract] [Full Text] [Related]

  • 27. [Effects of teriparatide and alendronate on bone mineral density of osteoporotic rats].
    Li M, Jiao J, Meng XW, Xing XP, Xia WB, Zhou XY, Liu HC, Jiang Y, Wang O, Hu YY, Zhan ZW.
    Zhonghua Yi Xue Za Zhi; 2005 Feb 02; 85(5):335-8. PubMed ID: 15854512
    [Abstract] [Full Text] [Related]

  • 28. Comparison of the effects of alendronate and risedronate on bone mineral density and bone turnover markers in postmenopausal osteoporosis.
    Sarioglu M, Tuzun C, Unlu Z, Tikiz C, Taneli F, Uyanik BS.
    Rheumatol Int; 2006 Jan 02; 26(3):195-200. PubMed ID: 15580349
    [Abstract] [Full Text] [Related]

  • 29. Postural stabilizing effect of alfacalcidol and active absorbable algal calcium (AAA Ca) compared with calcium carbonate assessed by computerized posturography.
    Fujita T, Nakamura S, Ohue M, Fujii Y, Miyauchi A, Takagi Y, Tsugeno H.
    J Bone Miner Metab; 2007 Jan 02; 25(1):68-73. PubMed ID: 17187196
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled clinical trial.
    Lane NE, Sanchez S, Modin GW, Genant HK, Pierini E, Arnaud CD.
    J Bone Miner Res; 2000 May 02; 15(5):944-51. PubMed ID: 10804025
    [Abstract] [Full Text] [Related]

  • 33. Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial.
    Greenspan SL, Bone HG, Ettinger MP, Hanley DA, Lindsay R, Zanchetta JR, Blosch CM, Mathisen AL, Morris SA, Marriott TB, Treatment of Osteoporosis with Parathyroid Hormone Study Group.
    Ann Intern Med; 2007 Mar 06; 146(5):326-39. PubMed ID: 17339618
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Alendronate in postmenopausal women with osteopenia and osteoporosis: effects on bone mineral density during treatment and after withdrawal].
    Jiang Y, Li M, Xia W, Xing X, Yu W, Tian J, Meng X, Zhou X.
    Zhonghua Yi Xue Za Zhi; 2002 Sep 25; 82(18):1254-6. PubMed ID: 12425805
    [Abstract] [Full Text] [Related]

  • 36. A 3-year pilot study with 1,25-dihydroxyvitamin D, calcium, and calcitonin for severe osteodystrophy in primary biliary cirrhosis.
    Floreani A, Zappala F, Fries W, Naccarato R, Plebani M, D'Angelo A, Chiaramonte M.
    J Clin Gastroenterol; 1997 Jun 25; 24(4):239-44. PubMed ID: 9252849
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism.
    Beshyah SA, Thomas E, Kyd P, Sharp P, Fairney A, Johnston DG.
    Clin Endocrinol (Oxf); 1994 Mar 25; 40(3):383-91. PubMed ID: 8187303
    [Abstract] [Full Text] [Related]

  • 40. A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss.
    Reginster JY, Deroisy R, Lecart MP, Sarlet N, Zegels B, Jupsin I, de Longueville M, Franchimont P.
    Am J Med; 1995 May 25; 98(5):452-8. PubMed ID: 7733123
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.